Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACTAVIS TOTOWA

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 44
  • 0 comments

FDA approve DESIPRAMINE HYDROCHLORIDE

Comment Full text

ACTAVIS TOTOWA

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 35
  • 0 comments

FDA approve DESIPRAMINE HYDROCHLORIDE

Comment Full text

ASCENT PHARMS INC

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 39
  • 0 comments

FDA approve BEXAROTENE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 42
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

HALEON US HOLDINGS

  • FDA Approval
  • Sept. 09, 2024, 18:34 UTC
  • 48
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Sept. 09, 2024, 15:16 UTC
  • 53
  • 0 comments

FDA approve EMPAGLIFLOZIN;LINAGLIPTIN

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Sept. 09, 2024, 13:25 UTC
  • 46
  • 0 comments

FDA approve TENOFOVIR ALAFENAMIDE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 09, 2024, 08:38 UTC
  • 56
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

BIONPHARMA

  • FDA Approval
  • Sept. 09, 2024, 08:38 UTC
  • 49
  • 0 comments

FDA approve IVABRADINE HYDROCHLORIDE

Comment Full text

CIPLA

  • FDA Approval
  • Sept. 09, 2024, 08:38 UTC
  • 44
  • 0 comments

FDA approve HYDROCORTISONE SODIUM SUCCINATE

Comment Full text
  • Previous
  • 359
  • 360
  • 361
  • 362
  • 363
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3374)
  • SEC News(216353)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137524)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin